
The International Conference on Systems Medicine, AI & Drug Repurposing
BerlinSeptember 23-25, 2026
Futurium
Save the date
Join us this September 23–25 in Berlin for the fifth edition of RExPO, Europe’s leading conference in the intersection of systems medicine, network pharmacology, Artificial Intelligence and drug repurposing.
RExPO26 brings together clinicians, researchers, industry leaders, SMEs, patient organizations, regulators, payers and policymakers to shape the next generation of mechanism-based precision therapeutics.
Choose your spot
EARLY BIRD PRICES
Registration will open soon – stay tuned!
GENERAL ADMISSION
FULL PASS
400 EUR
GENERAL ADMISSION
2-DAY PASS
360 EUR
GENERAL ADMISSION
DAY PASS (LIMITED)
210 EUR
START-UPS
FULL PASS
300 EUR
START-UPS
2-DAY PASS
260 EUR
START-UPS
DAY PASS (LIMITED)
150 EUR
ACADEMIA
FULL PASS
250 EUR
ACADEMIA
2-DAY PASS
210 EUR
ACADEMIA
DAY PASS (LIMITED)
130 EUR
PHD STUDENTS
FULL PASS
150 EUR
PHD STUDENTS
2-DAY PASS
130 EUR
PHD STUDENTS
DAY PASS (LIMITED)
90 EUR
PATIENTS & PATIENT ORGANISATIONS
FULL PASS
75 EUR
PATIENTS & PATIENT ORGANISATIONS
2-DAY PASS
65 EUR
PATIENTS & PATIENT ORGANISATIONS
DAY PASS (LIMITED)
40 EUR
Conference tracks
Unmet medical needs in cancer
Unmet medical needs in neurological diseases
The REMEDi4ALL sister project
Innovation in drug development & repurposing
Network medicine approaches to adverse drug event prediction for new & repurposed drugs
Translating to the global market
AI/ML in systems medicine & drug repurposing
Fostering mechanism-based repurposing around the globe
REPO4EU's drug repurposing platform
The last mile: accessibility for patient benefit
Computational drug repurposing
The role of IP in the drug repurposing business case
The patients' voice and patient-centricity
What are you waiting for?
Meet a vibrant community of researchers, clinicians and innovators that are redefining precision medicine from mechanism to patient impact.
OUR SPEAKERS
Our call for abstracts is now open
If your abstract is selected, you’ll have the chance to present your work either during our dedicated Poster Sessions or as one of the conference’s Main Talks.
KEY TOPICS
REPO4EU's drug repurposing platform
Don't miss the official launch of our platform's beta version, first live presentation and hands-on demonstration.
The EU drug repurposing ecosystem
Meet all the major initiatives in drug repurposing (including REPO4EU, REMEDi4ALL and RePo-SUDOE) in one place.
Rare diseases & precision therapeutics
New translational strategies for rare and ultra-rare diseases, from mechanism discovery to targeted intervention.
The Network Medicine Alliance
Systems-level approaches to disease mechanisms, patient stratification and therapeutic innovation, plus a keynote lecture by Joseph Loscalzo, one of the founding figures of Network Medicine.
Generative AI & real-world applications
Gen AI use cases in systems medicine, biomarker discovery, hypothesis generation and clinical decision support.
Clinical trial validation & PoC studies
First validation results from REPO4EU-associated clinical studies and translational pilots.
Open Science, publishing & data sharing
New models for transparent science, FAIR data and dissemination in biomedical publishing.
IP strategy, reimbursement & sustainable market access
From intellectual property frameworks to payer acceptance, pricing and long-term implementation.
Useful information for attendees
Where will the conference take place?
RExPO26 will be held at Futurium. The venue’s full address is: Alexanderufer 2, 10117 Berlin, Germany.
How do I get in touch?
For any topic related to RExPO26, please feel free to contact the conference office. We will be happy to help – you can reach us directly via email.
000 days 00 hours 00 minutes 00 seconds
UNTIL RExPO26
In collaboration with...
Our Platinum Sponsor
Buchanan’s Life Sciences Industry Group offers a rare and comprehensive mix of FDA Regulatory, Intellectual Property, Litigation and Government Relations services delivered through one seamless team. They counsel clients on the full range of issues that arise during the product lifecycle, from idea conception to commercialization. Their clients, which include leading pharmaceutical companies, biotechnology companies, wholesalers and distributors, retailers, industry trade associations and leading research institutions, trust Buchanan Life Sciences with their most challenging business and legal problems.










